NP90425 Faricimab (Vabysmo®)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-064dbd32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
11 Feb 2026
Description
Supply of Faricimab (Vabysmo®) to NHSScotland.
Scope
- Reference
- ocds-h6vhtk-064dbd
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Negotiated without publication of a contract notice
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Awarded suppliers· 1 supplier
Awarded —
Award value
—
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Roche Products Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| NHS National Framework for the supply of Tocilizumab Injection | contract | — | 30 Dec 2025 |
| NHS National Framework for the supply of Tocilizumab Injection | contract | — | 27 Nov 2025 |
| Baloxavir Marboxil Xofluza Antiviral | contract | — | 10 Oct 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | contract | — | 01 Aug 2025 |
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | contract | £47.0m | 29 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |